| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/06/2005 | CN1209115C Active extracted composition of teasel root and notoginseng and its use in medicine |
| 07/05/2005 | US6914158 Amidino compounds useful as nitric oxide synthase inhibitors |
| 07/05/2005 | US6914144 Process for preparing integrin antagonist intermediate |
| 07/05/2005 | US6914075 Cystine derivative and agent for suppressing activation of inflammatory factors |
| 07/05/2005 | US6914074 For therapy and prophylaxis of prostatitis or interstitial cystitis, inflammatory bowel disease, Crohn's disease, ulcerative proctitis, or colitis, prostatic hypertrophy, uterine leiomyomas, breast cancer, endometrial cancer |
| 07/05/2005 | US6914059 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 07/05/2005 | US6914050 Stimulation of bone growth with thrombin peptide derivatives |
| 07/05/2005 | US6913915 PEG-modified uricase |
| 07/05/2005 | US6913746 The polysaccharides in the complexes form an envelope which protects and carries immunoglobulins allowing their systemic absorption through gastric and mucosal membrane; polysacchride and immunoglobulins are bonded by ionic bonds |
| 07/05/2005 | CA2160928C Compounds as pde iv and tnf inhibitors |
| 06/30/2005 | WO2005058951A1 Sugar chain-lacking hepatocyte growth factor |
| 06/30/2005 | WO2005058338A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | WO2005058336A1 Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 06/30/2005 | WO2005058289A1 A method of preparing intranasal dry powders inhalant of calcitonin |
| 06/30/2005 | WO2004085388A3 Cyclic protein tyrosine kinase inhibitors |
| 06/30/2005 | WO2004078217A9 Bone calcification promoter |
| 06/30/2005 | WO2004002424A8 Mammalian epo mimetic ch1 deleted mimetibodies, compositions, methods and uses |
| 06/30/2005 | WO2003064629A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/30/2005 | US20050143578 Compounds and methods |
| 06/30/2005 | US20050143456 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
| 06/30/2005 | US20050143438 N3 alkylated benzimidazole derivatives as MEk inhibitors |
| 06/30/2005 | US20050143436 N-acylamino with fused nitrogen heterocyclic ring compound; capase enzyme inhibitors; antiinflammatory agents; oral bioavailability; autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, degenerative diseases, and necrotic diseases |
| 06/30/2005 | US20050143430 Catechol bioisosteres |
| 06/30/2005 | US20050143427 treating bone disorders of joint cartilage damage, osteoarthritis, rheumatoid arthritis, or joint inflammation, and pain associate with; antiinflammatory agent; 1-methyl-octahydroindole-2-carboxylic acid |
| 06/30/2005 | US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 06/30/2005 | US20050143401 Anticancer agents; (4-(3-Fluorobenzyloxy)-3-chlorophenyl)-(6-(2-((2-methanesulphonyl-ethylamino)ethyl)-thiazol-4-yl)-quinazolin-4-yl)-amine |
| 06/30/2005 | US20050143390 piperidines or piperazines 1-linked to a 1-(1-carbonylpiperidin-4-yl)piperidinyl- group through an optionally substituted methyl group; treating Human Immuno-deficiency Virus, solid organ transplant rejection, arthritis, rheumatoid arthritis, and multiple sclerosis |
| 06/30/2005 | US20050143379 Arylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 06/30/2005 | US20050143377 Bicyclic imidazole derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050142617 gene related to bone density; possible use in the drug screening, treatment, and diagnosis of bone disorders such as osteoporosis |
| 06/30/2005 | US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 06/30/2005 | US20050142138 Endothelial cell expression patterns |
| 06/30/2005 | CA2580663A1 Use of an extract of aloysia/verbena/lippia triphylla/citriodora for treating chronic and/or inflammatory diseases |
| 06/30/2005 | CA2550119A1 Use of gallium to treat inflammatory arthritis |
| 06/30/2005 | CA2549878A1 Glycosylation-deficient hepatocyte growth factor |
| 06/30/2005 | CA2549662A1 A method for the production of enriched hop extracts having combined oestrogenic and antiproliferative bioactivity |
| 06/30/2005 | CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof |
| 06/30/2005 | CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof |
| 06/29/2005 | EP1548121A1 Novel physiologically active substances |
| 06/29/2005 | EP1548029A2 Peptid- and peptide mimetic derivatives having integrin inhibitor properties III |
| 06/29/2005 | EP1548024A1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 06/29/2005 | EP1548015A1 Novel crystals |
| 06/29/2005 | EP1548008A1 Compound having tgf-beta inhibitory activity and medicinal composition containing the same |
| 06/29/2005 | EP1548003A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
| 06/29/2005 | EP1547617A1 Arthrodial cartilage extracellular matrix degradation inhibitor |
| 06/29/2005 | EP1547606A1 Method of preparing platelet rich plasma |
| 06/29/2005 | EP1547604A1 Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient |
| 06/29/2005 | EP1547600A1 Female hormone-containing patch |
| 06/29/2005 | EP1547585A1 Therapeutic agent for rheumatism containing benzamide derivative as active ingredient |
| 06/29/2005 | EP1546375A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 06/29/2005 | EP1546150A1 Biologically active compounds |
| 06/29/2005 | EP1546138A2 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 06/29/2005 | EP1546130A1 Novel piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 06/29/2005 | EP1546121A1 Substituted triazine kinase inhibitors |
| 06/29/2005 | EP1546117A2 Protein kinase inhibitors and uses thereof |
| 06/29/2005 | EP1546087A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 06/29/2005 | EP1546084A1 2,4-dihydroxybenzoic acid derivatives |
| 06/29/2005 | EP1545612A1 Modulation of mesenchymal cells via iga-receptors |
| 06/29/2005 | EP1545567A1 Pharmaceutical kits comprising mesenchymal stem cells |
| 06/29/2005 | EP1545564A1 Combination preparation of hyaluronic acid and at least one local anesthetic and the use thereof |
| 06/29/2005 | EP1545538A2 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 06/29/2005 | EP1545523A1 3-&-grave;(HETERO) ARYLMETHOXY ! PYRIDINES AND THEIR ANALOGUES ASP38 MAP KINASE INHIBITORS |
| 06/29/2005 | EP1545491A1 Therapeutic use of fused bicyclic or tricyclic amino acids |
| 06/29/2005 | EP1545475A1 Enteric composition for the manufacture of soft capsule wall |
| 06/29/2005 | EP1408943B1 Pharmaceutical formulation containing an ltb4 antagonist and a wetting agent |
| 06/29/2005 | EP1343786B1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 06/29/2005 | EP1315727B1 7-oxo pyridopyrimidines |
| 06/29/2005 | EP1274701B1 [1,4']-bipiperidine compounds |
| 06/29/2005 | EP1272507B1 Integrin binding peptide derivatives |
| 06/29/2005 | EP1119625B1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 06/29/2005 | EP1021186B1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha |
| 06/29/2005 | EP0901459B1 Calcilytic compounds |
| 06/29/2005 | EP0850055B1 Protein tyrosine kinase inhibitors for treating osteoarthritis |
| 06/29/2005 | CN1633499A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 06/29/2005 | CN1633498A Novel insulin/IGF/relaxin family polypeptides and dnas thereof |
| 06/29/2005 | CN1633433A N-aroyl cyclic amines |
| 06/29/2005 | CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 06/29/2005 | CN1633420A Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 06/29/2005 | CN1633416A Nicotinamide derivates useful as p38 inhibitors |
| 06/29/2005 | CN1633414A Chemical compounds |
| 06/29/2005 | CN1633301A Extracts from sophora, production method and purposes thereof |
| 06/29/2005 | CN1633300A Percutaneous preparations |
| 06/29/2005 | CN1633299A Estrogen replacement therapy |
| 06/29/2005 | CN1633297A Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 06/29/2005 | CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/29/2005 | CN1633294A 2, 4, 5-trisubstituded thiazolyl derivatives and their antiinflammatory activity |
| 06/29/2005 | CN1633288A Use of genistein in the manufacture of a medicament for the treatment of osteoporosis and obesity, and compositions containing genistein in combination with vitamin d and k |
| 06/29/2005 | CN1633284A Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/29/2005 | CN1633244A Aqueous chondro protective compositions having defined pH limitations for efficacious delivery |
| 06/29/2005 | CN1631430A Chinese medicinal ointment for treating bone diseases |
| 06/29/2005 | CN1631428A Chinese herbal composition for treating bone fracture and bone fissure |
| 06/29/2005 | CN1631416A Medicine for treating broken tendon and trauma and preparing process thereof |
| 06/29/2005 | CN1631383A Medicinal wine having therapeutic functions for scapulohumeral periarthritis, arthritis and pains of arms and legs |
| 06/29/2005 | CN1631364A Application of tanshinone óÄA in pharmacy |
| 06/29/2005 | CN1208333C Indole derivatives useful for the treatment of osteoporosis |
| 06/29/2005 | CN1208095C Medical composite biological bone cement powder, bone cement liquid and composite biological bore cement |
| 06/29/2005 | CN1208087C Method and compositions useful for modulation of angiogenesis using protein kinase Raf and Ras |
| 06/29/2005 | CN1208076C Medicinal composition for treating bone fracture |
| 06/29/2005 | CN1208072C Capsule for treating rheumatism, osteoporosis and hyperosteogeny disease and preparation method thereof |